Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
American Journal of Hematology|March 11, 1999
Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptivesG M Harris, C L Stendt, B J Vollenhoven, et al.The New Zealand Medical Journal|May 9, 1997
Neurotoxicity associated with acyclovir in end stage renal failureA R Kitching, D Fagg, N M Hay, et al.Journal of the American Society of Nephrology : JASN|March 12, 1999
Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritisM A Cunningham, X R Huang, J P Dowling, et al.The American Journal of Pathology|December 1, 1995
Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNAP G Tipping, J H Erlich, J Apostolopoulos, et al.The Journal of Experimental Medicine|February 9, 2000
Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritisM A Cunningham, E Rondeau, X Chen, et al.Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Endogenous alpha2-antiplasmin does not enhance glomerular fibrin deposition or injury in glomerulonephritisA R Kitching, A L Turner, K-M O'Sullivan, et al.Drug Development and Industrial Pharmacy|April 29, 1999
Macrophage depletion by albumin microencapsulated clodronate: attenuation of cytokine release in macrophage-dependent glomerulonephritisM J D'Souza, C W Oettinger, A Shah, et al.The Journal of Clinical Investigation|July 15, 1996
Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbitsJ H Erlich, J Apostolopoulos, T C Wun, et al.Kidney International|April 14, 1999
Tissue factor pathway inhibitor expression in human crescentic glomerulonephritisM A Cunningham, T Ono, T D Hewitson, et al.American Journal of Physiology. Renal Physiology|November 13, 2001
Crescentic glomerulonephritis is diminished in fibrinogen-deficient miceA F Drew, H L Tucker, H Liu, et al.Pageof 9